<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-7459</journal-id>
<journal-title><![CDATA[Horizonte sanitario]]></journal-title>
<abbrev-journal-title><![CDATA[Horiz. sanitario]]></abbrev-journal-title>
<issn>2007-7459</issn>
<publisher>
<publisher-name><![CDATA[Universidad Juárez Autónoma de Tabasco, División Académica de Ciencias de la Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-74592025000100248</article-id>
<article-id pub-id-type="doi">10.19136/hs.a24.1.6052</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Formación sobre Distrofia Muscular de Duchenne a profesionales de la salud en el Caribe Colombiano]]></article-title>
<article-title xml:lang="en"><![CDATA[Training healthcare professionals in The Colombian Caribbean on Duchenne Muscular Dystrophy]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Borja González]]></surname>
<given-names><![CDATA[Juana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Serrano Meriño]]></surname>
<given-names><![CDATA[Dolores Vanessa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Salas]]></surname>
<given-names><![CDATA[Roxana de las]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Orjuela Quintero]]></surname>
<given-names><![CDATA[Vanessa Paola]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ferreira Medina]]></surname>
<given-names><![CDATA[Yanina Johanna]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Orta Visbal]]></surname>
<given-names><![CDATA[Kevin Andrés]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad del Norte  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad del Norte  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad del Norte  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad del Norte  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Universidad del Norte  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,Universidad del Norte  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2025</year>
</pub-date>
<volume>24</volume>
<numero>1</numero>
<fpage>248</fpage>
<lpage>260</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-74592025000100248&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-74592025000100248&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-74592025000100248&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: Evaluar la validez de una intervención educativa para formar en distrofia muscular de duchenne (DMD) a profesionales de la salud, midiendo su nivel de satisfacción respecto a la misma.  Materiales y métodos: Se realizó una intervención educativa con 198 profesionales de los departamentos colombianos de Atlántico, Cesar, Magdalena y La Guajira, con el apoyo de un equipo interdisciplinario para el desarrollo de sesiones presenciales y material pedagógico, suministrado por medio de una plataforma virtual. Se aplicó al final de la intervención una encuesta de satisfacción con ocho preguntas de escala de Likert y dos preguntas abiertas sobre &#8220;Puntos a mejorar y sugerencias&#8221;.  Resultados: Ninguno de los puntajes que miden la satisfacción fueron inferiores a 5; el marcado predominio de calificaciones de diez (superiores, siempre, al 70%) expresan que esta es, en general, alta.  Conclusiones: Los participantes de la intervención educativa expresaron un alto nivel de satisfacción, ello abre la posibilidad de replicarlo al demostrarse pertinente para la educación continua en salud; no obstante, su validez se verá reforzada en la medida en que esta demuestre producir cambios en la condición de pacientes con DMD.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective:  To evaluate the validity of an educational intervention to train health professionals in Duchenne muscular dystrophy (DMD), measuring their level of satisfaction with it.  Materials and methods:  An educational intervention was carried out with 198 professionals from the Colombian departments of Atlántico, Cesar, Magdalena and La Guajira, with the support of an interdisciplinary team for the development of face-to-face sessions and pedagogical material, provided by means of a virtual platform. A satisfaction survey with eight Likert scale questions and two open questions on &#8220;Points to improve and suggestions&#8221; was applied at the end of the intervention.  Results:  None of the scores measuring satisfaction were lower than 5; the marked predominance of scores of ten (higher, always, than 70%) express that this is, in general, high.  Conclusions:  The participants of the educational intervention expressed a high level of satisfaction, this opens the possibility of replicating it as it proves to be relevant for continuing health education; however, its validity will be reinforced to the extent that it proves to produce changes in the condition of patients with DMD.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Distrofia Muscular de Duchenne]]></kwd>
<kwd lng="es"><![CDATA[Educación Médica Continua]]></kwd>
<kwd lng="es"><![CDATA[Diagnóstico]]></kwd>
<kwd lng="es"><![CDATA[Enfermedad Rara]]></kwd>
<kwd lng="es"><![CDATA[Enfermedad Huérfana]]></kwd>
<kwd lng="en"><![CDATA[Duchenne Muscular Dystrophy]]></kwd>
<kwd lng="en"><![CDATA[Continuing Medical Education]]></kwd>
<kwd lng="en"><![CDATA[Diagnosis]]></kwd>
<kwd lng="en"><![CDATA[Education]]></kwd>
<kwd lng="en"><![CDATA[Rare Disease]]></kwd>
<kwd lng="en"><![CDATA[Orphan Disease]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tapia]]></surname>
<given-names><![CDATA[FE]]></given-names>
</name>
<name>
<surname><![CDATA[Mendiolea]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[NI]]></given-names>
</name>
<name>
<surname><![CDATA[Cuesta]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
<name>
<surname><![CDATA[Bocero]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Distrofia muscular de Duchenne y cetoacidosis euglucémica por ayuno: a propósito de un caso]]></article-title>
<source><![CDATA[Rev Clínica Española]]></source>
<year>2023</year>
<volume>223</volume>
<page-range>S503-4</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Venugopal]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Pavlakis]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Duchenne Muscular Dystrophy]]></source>
<year>2024</year>
<publisher-loc><![CDATA[Treasure Island (FL) ]]></publisher-loc>
<publisher-name><![CDATA[StatPearls Publishing]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Triana-Fonseca]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Parada-Márquez]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Silva-Aldana]]></surname>
<given-names><![CDATA[CT]]></given-names>
</name>
<name>
<surname><![CDATA[Zambrano-Arenas]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Arias-Gomez]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Morales-Fonseca]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genetic profile of the dystrophin gene reveals new mutations in colombian patients affected with muscular dystrophinopathy]]></article-title>
<source><![CDATA[Appl Clin Genet]]></source>
<year>2021</year>
<volume>14</volume>
<page-range>399-408</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rudebeck]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rhodes]]></surname>
<given-names><![CDATA[NP]]></given-names>
</name>
<name>
<surname><![CDATA[van Kan]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Olsson]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Al-sbou]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical development innovation in rare diseases: lessons learned and best practices from the DevelopAKUre consortium]]></article-title>
<source><![CDATA[Orphanet J Rare Dis]]></source>
<year>2021</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Al-Attar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Butterworth]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[McKay]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A quantitative and qualitative analysis of patient group narratives suggests common biopsychosocial red flags of undiagnosed rare disease]]></article-title>
<source><![CDATA[Orphanet J Rare Dis]]></source>
<year>2024</year>
<volume>19</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-12</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[29 de febrero: Día Mundial de las Enfermedades Raras]]></source>
<year>2024</year>
<publisher-name><![CDATA[Sociedad Española de Neurología]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Richardson]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Rice]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lyon]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kobernick]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Brackbill]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of mental health in persons living with rare disease: Findings from the AMCP Market Insights Program]]></article-title>
<source><![CDATA[J Manag Care Spec Pharm]]></source>
<year>2024</year>
<volume>30</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>s1-s12</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Munro]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Cook]]></surname>
<given-names><![CDATA[A. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Bogart]]></surname>
<given-names><![CDATA[K. R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An inductive qualitative content analysis of stigma experienced by people with rare diseases]]></article-title>
<source><![CDATA[Psychology &amp; Health]]></source>
<year>2021</year>
<volume>37</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>948-63</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rao]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Yabumoto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ward-Lev]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Naik]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Halley]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Health-related quality of life in patients with diverse rare diseases: An online survey]]></article-title>
<source><![CDATA[Genet Med Open]]></source>
<year>2024</year>
<volume>2</volume>
<page-range>1-11</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heutinck]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[van Gameren]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Verschuuren]]></surname>
<given-names><![CDATA[JJGM]]></given-names>
</name>
<name>
<surname><![CDATA[Geurts]]></surname>
<given-names><![CDATA[ACH]]></given-names>
</name>
<name>
<surname><![CDATA[Jansen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[de Groot]]></surname>
<given-names><![CDATA[IJM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical Management of Duchenne Muscular Dystrophy in the Netherlands: Barriers to and Proposals for the Implementation of the International Clinical Practice Guidelines]]></article-title>
<source><![CDATA[Journal of Neuromuscular Diseases]]></source>
<year>2021</year>
<volume>8</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>503-12</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>Instituto Nacional de Salud</collab>
<source><![CDATA[Informe de evento enfermedades huérfanas-raras. Periodo epidemiológico XIII, Colombia, 2020]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Farrar]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Kariyawasam]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Grattan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy: First Workshop Report: Establishing Australian health system readiness for the implementation and evaluation of a pilot program in New South Wales and the Australian Capital Territory]]></article-title>
<source><![CDATA[Journal of Neuromuscular Diseases]]></source>
<year>2022</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>15-28</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Turnage]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Sutyla]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mitchell]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lindahl]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Jesus]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Hidden Disease: Delayed Diagnosis in Duchenne Muscular Dystrophy and Co-Occurring Conditions]]></article-title>
<source><![CDATA[J Dev Behav Pediatr]]></source>
<year>2022</year>
<volume>43</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>e541-5</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mercuri]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pane]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cicala]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Brogna]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ciafaloni]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Detecting early signs in Duchenne muscular dystrophy: comprehensive review and diagnostic implications]]></article-title>
<source><![CDATA[Front Pediatr]]></source>
<year>2023</year>
<volume>11</volume>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Handa]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Gaidhane]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Choudhari]]></surname>
<given-names><![CDATA[S. G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical Insights and Multidisciplinary Tertiary Prevention in Duchenne Muscular Dystrophy: A Case Report]]></article-title>
<source><![CDATA[Anatolian Journal of Family Medicine]]></source>
<year>2024</year>
<volume>7</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Goemans]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Takeda]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mercuri]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Aartsma-Rus]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Duchenne Muscular Dystrophy]]></article-title>
<source><![CDATA[Nat Rev Dis Primers]]></source>
<year>2021</year>
<volume>7</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>1-19</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patterson]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Conner]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Groneman]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Blavo]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Parmar]]></surname>
<given-names><![CDATA[M. S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Duchenne muscular dystrophy: Current treatment and emerging exon skipping and gene therapy approach]]></article-title>
<source><![CDATA[European Journal of Pharmacology]]></source>
<year>2023</year>
<volume>947</volume>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patterson]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Conner]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Groneman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Blavo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Parmar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Duchenne muscular dystrophy: Current treatment and emerging exon skipping and gene therapy approach]]></article-title>
<source><![CDATA[Eur J Pharmacol]]></source>
<year>2023</year>
<volume>947</volume>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bu&#382;gová]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Kozáková]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Bar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effect of neuropalliative care on quality of life and satisfaction with quality of care in patients with progressive neurological disease and their family caregivers: an interventional control study]]></article-title>
<source><![CDATA[BMC Palliat Care]]></source>
<year>2020</year>
<volume>19</volume>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hammer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Toussaint]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vollsæter]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tvedt]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Røksund]]></surname>
<given-names><![CDATA[OD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exercise Training in Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis]]></article-title>
<source><![CDATA[J Rehabil Med]]></source>
<year>2022</year>
<volume>54</volume>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<collab>NewsRARE</collab>
<source><![CDATA[Casos de éxito en pacientes con enfermedades raras y su entorno]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<collab>Organización de las Naciones Unidas</collab>
<article-title xml:lang=""><![CDATA[Resolución aprobada por la Asamblea General el 10 de Octubre de 2019 sobre la &#8220;cobertura universal en salud&#8221;]]></article-title>
<source><![CDATA[]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="">
<collab>Organización de las Naciones Unidas</collab>
<article-title xml:lang=""><![CDATA[Resolución aprobada por la Asamblea General el 19 de Diciembre 2023 sobre &#8220;Abordar los retos de las personas que viven con una enfermedad rara y de sus familias&#8221;]]></article-title>
<source><![CDATA[]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tumiene]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Peters]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Melegh]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rare disease education in Europe and beyond: time to act]]></article-title>
<source><![CDATA[Orphanet J Rare Dis]]></source>
<year>2022</year>
<volume>17</volume>
<numero>441</numero>
<issue>441</issue>
<page-range>1-20</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Groft]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Gopal-Srivastava]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dellon]]></surname>
<given-names><![CDATA[ES]]></given-names>
</name>
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How to Advance Research, Education, and Training in the Study of Rare Diseases]]></article-title>
<source><![CDATA[Gastroenterology]]></source>
<year>2019</year>
<volume>157</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>917-21</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dunne]]></surname>
<given-names><![CDATA[TF]]></given-names>
</name>
<name>
<surname><![CDATA[Jeffries]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[McKay]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rare disease 101: an online resource teaching on over 7000 rare diseases in one short course]]></article-title>
<source><![CDATA[Orphanet J Rare Dis]]></source>
<year>2024</year>
<volume>19</volume>
<numero>275</numero>
<issue>275</issue>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Drexel]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Brandsema]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[DelNido]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Turell]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recognition and Management of Duchenne Muscular Dystrophy: Knowledge and Behavior Changes from Continuing Education (2420)]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2021</year>
<volume>96</volume>
<numero>^s15</numero>
<issue>^s15</issue>
<supplement>15</supplement>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Domaradzki]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Walkowiak]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Knowledge and Attitudes of Future Healthcare Professionals Toward Rare Diseases]]></article-title>
<source><![CDATA[Front Genet]]></source>
<year>2021</year>
<volume>12</volume>
<numero>May</numero>
<issue>May</issue>
<page-range>1-11</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
